Advancing Life Science Solutions Through Translational Innovation
Pioneering translational biotechnology solutions to deliver tomorrow’s medicines today.
Pioneering translational biotechnology solutions to deliver tomorrow’s medicines today.
Our cutting edge know-how in GMP manufacturing and clinical application of advanced therapeutic medicinal products (ATMPs) enables the clinical application of next generation advanced therapeutics.
Vivosel develops mesenchymal stem cell (MSC) platforms and engineered exosomes designed for therapeutic applications across regenerative medicine, hair loss, and anti-aging treatments. All products are processed from ethically sourced human tissue and manufactured under GMP-compliant conditions.
Learn moreWe offer end-to-end GMP process development for gene editing applications, including vector design, cell engineering, and quality-controlled production. Our platforms support transgene delivery using lentiviral and non-viral vectors tailored for clinical-grade use.
Learn moreVivosel produces high-quality, GMP-grade cell lines and raw materials essential for clinical research and therapy development. Our cell products are manufactured under strict GMP conditions to ensure consistency, sterility, and regulatory compliance — supporting both autologous and allogeneic cell-based therapies.
Learn moreVivosel is a biotechnology company specializing in translational biotechnology, transforming advanced research into clinical-grade gene and cell therapies to meet urgent healthcare needs.
With over 40 clinical trials in the US, Europe, and Türkiye, Vivosel is a pioneer in manufacturing CAR-T cells, engineered exosomes, and mesenchymal stem cells for therapeutic use.
Our pilot GMP facility at Teknopark İstanbul supports every stage of translational biotechnology, from R&D to clinical-grade ATMP manufacturing.
Two 50 m² cleanroom suites support GMP-compliant cell culture, gene editing, and therapeutic biologic production for clinical applications.
In-house QC ensures every product meets EMA and FDA-aligned standards for identity, sterility, potency, and consistency.
Temperature- and security-controlled areas support master/working cell banks, vector libraries, and long-term biologic storage.
R&D programs focus on engineered exosomes, advanced MSC modifications, and GMP-grade viral/non-viral gene delivery systems.
Advancing translational biotechnology — from concept to clinic.
Established R&D operations at Boğaziçi University Life Sciences Center, initiating MSC and exosome platform research.
Opened GMP pilot manufacturing suite at Teknopark İstanbul with cleanrooms, QC lab, and banking capabilities.
Achieving GMP production of stem cells, exosomes, and lentiviral vectors for preclinical and clinical partners.
Development of engineered exosome therapeutics and customized gene-editing toolkits with global partnership outreach.
Expansion of export-ready, GMP-compliant ATMP components and biologics to international clinical and research partners.
Have questions or want to explore partnership opportunities? Our team is here to help.
info@vivosel.com
Sanayi Mah. Teknopark Blv. No:1/4C, İç Kapı No:313, Pendik/İSTANBUL